Clinical trial

Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic…

NCT00004860 · Eastern Cooperative Oncology Group, Other · Completed

Key facts

NCT number NCT00004860
Title Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer
Official title A Phase II Study of ORZEL (UFT + Leucovorin) in Elderly (at Least 75 Years Old) Patients With Colorectal Cancer
Lead sponsor Eastern Cooperative Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Colorectal Cancer
Intervention type Drug
Interventions leucovorin calcium, tegafur-uracil
Start date Oct 9, 2000
Primary completion Oct 1, 2005
First posted Apr 12, 2004
Last update posted Jun 15, 2023
Countries Puerto Rico, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies